Impact of GAMP 5, data integrity and QbD on quality assurance in the pharmaceutical industry: How obvious is it?

被引:3
|
作者
Pedro, Francisca [1 ]
Veiga, Francisco [1 ,2 ]
Mascarenhas-Melo, Filipa [1 ,2 ]
机构
[1] Univ Coimbra, Fac Pharm, Drug Dev & Technol Lab, Coimbra, Portugal
[2] Univ Coimbra, Fac Pharm, REQUIMTE LAQV, Grp Pharmaceut Technol, Coimbra, Portugal
关键词
Good Automated Manufacturing Practices; GAMP; 5; Data Integrity; QbD; Computerized System Validation; Pharmaceutical Industry; Drug; Quality Assurance; REGULATORY COMPLIANCE; DESIGN; MANAGEMENT; SYSTEMS; FUTURE;
D O I
10.1016/j.drudis.2023.103759
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
In the pharmaceutical industry, it is essential to ensure the safety and efficacy of medicinal products. Therefore a robust quality assurance framework is needed. This manuscript examines the impact of GAMP 5 and data integrity (DI) on quality assurance, while also highlighting the role of quality by design (QbD) principles. GAMP 5 is a widely used framework for validating automated systems that establishes quality assurance practices. DI guarantees the reliability of data collected throughout various stages of drug development. The integration of QbD principles promotes a systematic approach to development that emphasizes a deep understanding of critical quality attributes, risk management, and continuous improvement. With their implementation, organizations are able to meet regulatory requirements and provide safe medications to patients worldwide.
引用
收藏
页数:9
相关论文
共 22 条
  • [1] Data Integrity in Pharmaceutical Industry
    Bojnanska, E.
    Jampilek, J.
    CHEMICKE LISTY, 2018, 112 (04): : 227 - 231
  • [2] Quality Assurance of Intermediate Qualifications in the Pharmaceutical Industry
    Arbizu Echavarri, Francisca
    REVISTA DIGITAL DE INVESTIGACION EN DOCENCIA UNIVERSITARIA-RIDU, 2018, 12 (02): : 180 - 203
  • [3] An Ontology based Conceptualization of Data Integrity Regulatory Compliance in Pharmaceutical Industry: The SPuMoNI Case
    Lallas, Efthimios
    Santouridis, Ilias
    Mountzouris, Georgios
    Gerogiannis, Vassilis C.
    Karageorgos, Anthony
    25TH PAN-HELLENIC CONFERENCE ON INFORMATICS WITH INTERNATIONAL PARTICIPATION (PCI2021), 2021, : 460 - 465
  • [4] Rethinking Pharmaceutical Industry with Quality by Design: Application in Research, Development, Manufacturing, and Quality Assurance
    Joana Galvão Duarte
    Maria Galvão Duarte
    Ana Paula Piedade
    Filipa Mascarenhas-Melo
    The AAPS Journal, 27 (4)
  • [5] Measuring the performance of quality assurance processes: pharmaceutical industry deviation management case study
    Zorana Boltic
    Nenad Ruzic
    Mica Jovanovic
    Slobodan Petrovic
    Accreditation and Quality Assurance, 2010, 15 : 629 - 636
  • [6] Measuring the performance of quality assurance processes: pharmaceutical industry deviation management case study
    Boltic, Zorana
    Ruzic, Nenad
    Jovanovic, Mica
    Petrovic, Slobodan
    ACCREDITATION AND QUALITY ASSURANCE, 2010, 15 (11) : 629 - 636
  • [7] Data integrity issues in pharmaceutical industry: Common observations, challenges and mitigations strategies
    Charoo, Naseem A.
    Khan, Mansoor A.
    Rahman, Ziyaur
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2023, 631
  • [8] CONTINUOUS IMPROVEMENT CONCEPTS AS A LINK BETWEEN QUALITY ASSURANCE AND IMPLEMENTATION OF CLEANER PRODUCTION - CASE STUDY IN THE GENERIC PHARMACEUTICAL INDUSTRY
    Boltic, Zorana
    Jovanovic, Mica
    Petrovic, Slobodan
    Bozanic, Vojislav
    Mihajlovic, Marina
    CHEMICAL INDUSTRY & CHEMICAL ENGINEERING QUARTERLY, 2016, 22 (01) : 55 - 64
  • [9] Track and trace: Ensuring data integrity and regulatory compliance for chromatography methods in the pharmaceutical industry
    Kenny, Patrick
    Manufacturing Chemist, 2020, 91 (03): : 22 - 24
  • [10] QUALITY ASSURANCE IN THE MEAT INDUSTRY SUPPORTED BY ELECTRONIC-DATA-PROCESSING
    TIELMANN, J
    FLEISCHWIRTSCHAFT, 1993, 73 (05): : 522 - 525